Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Ocular Therapeutix Inc (NASDAQ:OCUL)

22.06
Delayed Data
As of 11:52am ET
 +0.01 / +0.05%
Today’s Change
12.20
Today|||52-Week Range
44.19
-6.21%
Year-to-Date
No recent news for Ocular Therapeutix Inc.

Today’s Trading

Previous close22.05
Today’s open22.18
Day’s range21.94 - 22.46
Volume23,574
Average volume (3 months)248,890
Market cap$570.4M
Dividend yield--
Data as of 11:52am ET, 08/04/2015

Growth & Valuation

Earnings growth (last year)-668.57%
Earnings growth (this year)+48.70%
Earnings growth (next 5 years)--
Revenue growth (last year)--
P/E ratioNM
Price/Sales324.55
Price/Book8.39

Competitors

 Today’s
change
Today’s
% change
ANGOAngioDynamics Inc+0.05+0.32%
ANIKAnika Therapeutics I...-0.91-2.45%
BLCMBellicum Pharmaceuti...-0.34-1.69%
INOInovio Pharmaceutica...-0.05-0.69%
Data as of 12:06pm ET, 08/04/2015

Financials

Next reporting dateAugust 28, 2015
EPS forecast (this quarter)-$0.33
Annual revenue (last year)$772.0K
Annual profit (last year)-$28.6M
Net profit margin-3,710.88%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
Chairman, President &
Chief Executive Officer
Amarpreet S. Sawhney
Chief Operating Officer
James Fortune
Corporate headquarters
Bedford, Massachusetts

Forecasts